The compound, developed by Amylyx Pharma, is called RELYVRIO and is capable of slowing down the degeneration caused by this disease.
Part of his clinical studies were financed with funds from the ice bucket challenge.Sept.
30, 2022
The FDA approves a drug that fights Amyotrophic Lateral Sclerosis
2022-10-01T15:42:55.306Z
The compound, developed by Amylyx Pharma, is called RELYVRIO and is capable of slowing down the degeneration caused by this disease. Part of his clinical studies were financed with funds from the ice bucket challenge.